ST PHARM CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 101,800 KRW | +5.93% |
|
+9.94% | +50.15% |
| 2023 | ST Pharm Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
| 2021 | ST Pharm Co.,Ltd. Announces Expansion of Oligonucleotide Facility | CI |
Chart calendar ST Pharm Co.,Ltd.
72d.ogq-avqJi0Cdh9xPt_1l6_GGwcJUfAz-kKKEHqTFHS4.zkn8G7PB-Q7uqqQj3LEQhpXjg6ZjUX6U987DdMe1ZETNbsoQk73pFe_TnQ~b30410059104d81766d1829e25078cef
Upcoming events on ST Pharm Co.,Ltd.
Past events on ST Pharm Co.,Ltd.
| 2024-05-12 09:00 pm | Macquarie Asia Conference |
| 2024-05-08 08:10 pm | Non Deal Roadshow - Day 2 |
| 2024-05-07 08:10 pm | Non Deal Roadshow - Day 1 |
| 2024-05-02 01:30 am | Q1 2024 Earnings Call |
| 2024-05-01 | Q1 2024 Earnings Release |
| 2024-03-19 | Non Deal Roadshow |
| 2024-02-28 07:10 pm | Non Deal Roadshow - Day - 1 |
| 2024-02-19 07:10 pm | Non Deal Roadshow - Day - 2 |
| 2024-02-01 01:15 am | Q4 2023 Earnings Call |
| 2024-01-31 | Q4 2023 Earnings Release |
| 2023-12-20 12:00 am | Investor Meeting |
| 2023-12-04 08:30 pm | Investor Meeting |
| 2023-11-01 08:10 pm | Non Deal Roadshow |
| 2023-10-30 | Q3 2023 Earnings Release |
| 2023-08-24 | Non Deal Roadshow - Day - 3 |
| 2023-08-23 | Non Deal Roadshow - Day - 2 |
| 2023-08-22 | Non Deal Roadshow - Day - 1 |
| 2023-07-27 03:00 am | Q2 2023 Earnings Call |
| 2023-07-26 | Q2 2023 Earnings Release |
| 2023-05-30 08:30 pm | Roadshow - Day - 2 |
Past dividends on ST Pharm Co.,Ltd.
| 2023-12-26 | Annual 500 KRW |
| 2022-12-27 | Annual 500 KRW |
| 2021-12-28 | Annual 500 KRW |
| 2018-12-26 | Annual 500 KRW |
| 2017-12-26 | Annual 500 KRW |
| 2016-12-27 | Annual 500 KRW |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 93,3 | 124 137 -9.38% | 166 170 -2.6% | 249 233 7.23% | 284 281 0.97% | 329 |
|
EBITDA Billions KRW | Released Forecast Spread | 0,00 | -4,75 -3,00 -58.31% | 20,0 25,9 -22.81% | 35,5 33,1 7.07% | 56,5 52,8 7.09% | 65,2 |
|
EBIT Billions KRW | Released Forecast Spread | 0,00 | -18,8 -16,0 -17.74% | 5,58 10,9 -48.67% | 18,8 18,0 4.84% | 33,4 29,9 11.98% | 43,6 |
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | 0,00 | -16,8 -5,00 -236.8% | 7,97 13,3 -40.26% | 20,2 22,6 -10.63% | 23,4 27,5 -15.08% | 45,1 |
|
Net income Billions KRW | Released Forecast Spread | 0,00 | -12,1 -1,00 -1114.72% | 4,71 11,6 -59.5% | 18,8 21,2 -11.13% | 17,5 22,7 -22.86% | 37,7 |
|
EPS KRW | Released Forecast Spread | -993 | -651 -37,0 -1659.46% | 177 615 -71.22% | 1 002 897 11.69% | 1 041 1 212 -14.09% | 2 022 |
| Announcement Date | 13/03/20 | 19/02/21 | 24/02/22 | 16/02/23 | 01/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Billions KRW | Released Forecast Spread | 51,7 48,3 7.11% | 37,0 41,3 -10.46% | 51,1 46,1 10.9% | 60,8 65,8 -7.59% | 100 86,3 16.29% | 50,6 55,6 -8.97% | 57,8 60,5 -4.53% | 55,9 73,4 -23.76% | 120 116 3.5% | 51,7 55,6 -6.89% | 67,5 | 73,6 | 130 | 75,7 |
|
EBITDA Billions KRW | Released Forecast Spread | 8,66 11,2 -22.69% | 16,1 11,8 36.57% | 8,95 11,0 -18.63% | 6,93 10,5 -34.03% | 7,89 8,70 -9.28% | 13,9 | 15,6 | 23,7 | ||||||
|
EBIT Billions KRW | Released Forecast Spread | -0,56 1,40 -140.29% | 0,54 0,30 79% | 3,54 3,70 -4.46% | 4,54 7,81 -41.86% | 10,2 9,61 6.37% | 3,71 5,40 -31.31% | 1,61 3,72 -56.77% | 6,67 8,51 -21.67% | 21,4 17,7 21.28% | 1,88 4,58 -59% | 4,20 | 9,30 | ||
|
Earnings before Tax (EBT) Billions KRW | Released Forecast Spread | -4,91 0,10 -5010% | -0,22 1,30 -116.77% | 4,64 6,20 -25.15% | 11,9 12,1 -2.13% | 3,92 4,69 -16.41% | 0,99 5,60 -82.25% | 5,10 9,00 -43.34% | 12,3 16,6 -25.96% | 7,51 6,50 15.51% | 6,90 | 8,10 | 33,9 | 12,3 | |
|
Net income Billions KRW | Released Forecast Spread | -3,13 0,10 -3226% | 1,91 1,00 90.7% | 3,40 4,80 -29.1% | 10,2 6,10 67.15% | 3,34 4,44 -24.81% | 3,79 | 1,33 4,30 -69.02% | 3,93 7,00 -43.84% | 9,43 14,2 -33.62% | 6,23 5,05 23.45% | 4,40 | 9,60 | ||
|
EPS KRW | Released Forecast Spread | 201 | |||||||||||||
| Announcement Date | 24/02/22 | 28/04/22 | 08/08/22 | 31/10/22 | 16/02/23 | 28/04/23 | 27/07/23 | 31/10/23 | 01/02/24 | 02/05/24 | - | - | - | - |
More events
Past sector events for ST Pharm Co.,Ltd.
| Today | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| Today | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 10:05 am | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 01:30 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-15 07:40 am | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-15 03:03 am | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-14 05:43 pm | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 04:52 am | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-14 01:30 am | BAYER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- A237690 Stock
- Calendar ST Pharm Co.,Ltd.
